Navigation Links
Is transgenic cotton more profitable?
Date:2/18/2008

MADISON, WI, FEBRUARY 11, 2008 -- Transgenic cotton cultivars were planted on almost 93% of U.S. cotton acres in 2007. Transgenic cultivars with pest-managing traits are dual-purpose products. The cultivars produce lint and seed, while the expressed propriety traits provide part of the crops insect management and/or enable use of broad-spectrum herbicides for weed management.

Growers must choose among an increasing number of cultivars and an increasingly diverse spectrum of pest management options linked to the cultivars. In recent years, the number of different transgenic cotton production options that a grower may purchase has outpaced the capacity of the official cultivar trials (OCTs) to adequately evaluate their economic value.

First, large numbers of cultivars are being offered; but moreover OCTs when conducted with uniform, and generally very high levels of pest management, do not fully assess the value of the transgenic cultivars. In fact, the pest management options and their associated potential for cost reductions are the principal features of the current transgenic cultivars.

This paper addresses the challenges posed by the advent of transgenic, pest-managing technologies, and directly addresses the question most relevant to growers, Will transgenic cultivars return more profit" Results from the study were published in the January-February 2008 issue of Agronomy Journal.

Field experiments were conducted from 2001-2004 to compare production systems utilizing cotton cultivars possessing different transgenic technologies. Cultivars of each type of technology were managed in accordance with their respective genetic capabilities. In 2001 and 2002 selection of the Roundup Ready technology system resulted in reduced returns to the producer, while higher returns were attained from non-transgenic, Bollgard and Bollgard/Roundup Ready technologies. Cultivar differences were noted among the non-transgenic cultivars.

Again in 2003, selection of the transgenic cultivars reduced returns, while similar, higher returns were attained from non-transgenic technologies.

According to the authors, Collectively these results indicate that profitability was most closely associated with yields and not the transgenic technologies. Continued research is necessary to analyze the 2005 and 2006 results with more recent types of transgenic cotton cultivars.


'/>"/>

Contact: Sara Uttech
suttech@agronomy.org
608-268-4948
American Society of Agronomy
Source:Eurekalert

Related biology news :

1. Transgenics transformed
2. Transgenic maize is more susceptible to aphids
3. Inquiring minds want to know about cotton fleahoppers
4. Inquiring minds want to know about cotton fleahoppers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:11/14/2016)... , Nov. 14, 2016  Based ... identification market, Frost & Sullivan recognizes FST ... Sullivan Award for Visionary Innovation Leadership. FST ... the biometric identification market by pioneering In ... solution for instant, seamless, and non-invasive verification. ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces ... at the Company,s Annual and Special Meeting. ... place on Thursday, December 15, 2016 at Mount ... EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta ... meeting and management information circular, containing the matters to be ...
Breaking Biology Technology: